Apollomics Statistics
Total Valuation
Apollomics has a market cap or net worth of $27.59 million. The enterprise value is $24.85 million.
Important Dates
The last earnings date was Monday, April 27, 2026, before market open.
| Earnings Date | Apr 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Apollomics has 2.15 million shares outstanding. The number of shares has increased by 41.67% in one year.
| Current Share Class | 2.15M |
| Shares Outstanding | 2.15M |
| Shares Change (YoY) | +41.67% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 47.07% |
| Owned by Institutions (%) | 4.96% |
| Float | 1.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.06 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.96
| Current Ratio | 0.96 |
| Quick Ratio | 0.88 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -138.14 |
Financial Efficiency
Return on equity (ROE) is -1,305.37% and return on invested capital (ROIC) is -341.67%.
| Return on Equity (ROE) | -1,305.37% |
| Return on Assets (ROA) | -56.65% |
| Return on Invested Capital (ROIC) | -341.67% |
| Return on Capital Employed (ROCE) | -2,314.18% |
| Weighted Average Cost of Capital (WACC) | 14.18% |
| Revenue Per Employee | $691,846 |
| Profits Per Employee | -$841,462 |
| Employee Count | 13 |
| Asset Turnover | 0.91 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Apollomics has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +95.88% in the last 52 weeks. The beta is 1.83, so Apollomics's price volatility has been higher than the market average.
| Beta (5Y) | 1.83 |
| 52-Week Price Change | +95.88% |
| 50-Day Moving Average | 17.56 |
| 200-Day Moving Average | 14.23 |
| Relative Strength Index (RSI) | 31.29 |
| Average Volume (20 Days) | 9,989 |
Short Selling Information
The latest short interest is 6,089, so 0.28% of the outstanding shares have been sold short.
| Short Interest | 6,089 |
| Short Previous Month | 8,562 |
| Short % of Shares Out | 0.28% |
| Short % of Float | 0.54% |
| Short Ratio (days to cover) | 0.71 |
Income Statement
In the last 12 months, Apollomics had revenue of $8.99 million and -$10.94 million in losses. Loss per share was -$7.57.
| Revenue | 8.99M |
| Gross Profit | 8.99M |
| Operating Income | -8.98M |
| Pretax Income | -10.94M |
| Net Income | -10.94M |
| EBITDA | -8.93M |
| EBIT | -8.98M |
| Loss Per Share | -$7.57 |
Full Income StatementBalance Sheet
The company has $3.28 million in cash and $643,000 in debt, giving a net cash position of $2.63 million or $1.23 per share.
| Cash & Cash Equivalents | 3.28M |
| Total Debt | 643,000 |
| Net Cash | 2.63M |
| Net Cash Per Share | $1.23 |
| Equity (Book Value) | -3.19M |
| Book Value Per Share | -1.45 |
| Working Capital | -275,000 |
Full Balance SheetCash Flow
| Operating Cash Flow | -10.37M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 46,000 |
| Net Borrowing | -125,000 |
| Free Cash Flow | -10.37M |
| FCF Per Share | -$4.83 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -99.83% and -121.63%.
| Gross Margin | 100.00% |
| Operating Margin | -99.83% |
| Pretax Margin | -121.59% |
| Profit Margin | -121.63% |
| EBITDA Margin | -99.32% |
| EBIT Margin | -99.83% |
| FCF Margin | n/a |